Glassia Injection, Solution
Product Images NDC 0944-2884

11 FDA label images from Takeda Pharmaceuticals America, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Glassia (NDC 0944-2884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gla00 0016 01

Gla00 0016 01
Illustration showing a gloved hand holding an injection vial, likely representing the intravenous injection form of GLASSIA 1 g/50 mL, alpha-1-proteinase inhibitor human, a plasma derivative from Takeda Pharmaceuticals America, Inc.*
FDA Label Image

Gla00 0016 02

Gla00 0016 02
An illustration showing a gloved hand removing a cap from the top of a clear vial containing liquid medication, demonstrating the preparation step of the GLASSIA 1 g/50 mL intravenous injection solution.*
FDA Label Image

Gla00 0016 03

Gla00 0016 03
An instructional illustration showing a pair of gloved hands holding a vial and a syringe. The syringe is being inserted into the vial, demonstrating how to draw liquid medication. This image likely relates to preparation of an intravenous injection solution such as Glassia (Alpha-1-Proteinase Inhibitor Human).*
FDA Label Image

Gla00 0016 04

Gla00 0016 04
An instructional illustration showing a gloved hand holding a syringe with a vial, demonstrating preparation for intravenous injection. It depicts the correct technique of drawing solution from a vial into the syringe, relevant to the administration of injectable medications such as GLASSIA (alpha1-proteinase inhibitor human) injection, solution.*
FDA Label Image

Gla00 0016 05

Gla00 0016 05
An instructional illustration showing a gloved hand holding a medical connector attached to an intravenous line, demonstrating connection setup for intravenous injection administration.*
FDA Label Image

Gla00 0016 06

Gla00 0016 06
An instructional illustration showing a pair of gloved hands preparing an intravenous injection by connecting or handling a vial or solution container. The image focuses on proper handling technique for preparing GLASSIA, an alpha1-proteinase inhibitor human injection solution by Takeda Pharmaceuticals America, Inc.*
FDA Label Image

Gla00 0016 07

Gla00 0016 07
An illustration showing the placement of a tourniquet on the upper arm in preparation for intravenous injection. A gloved hand is applying an alcohol swab to the inner forearm area, likely for skin disinfection prior to venipuncture or injection.*
FDA Label Image

Gla00 0016 08

Gla00 0016 08
An instructional illustration showing a healthcare professional wearing blue gloves administering an intravenous injection through a patient's arm. The image depicts the intravenous line connected to the injection site, demonstrating the process of intravenous medication administration.*
FDA Label Image

Gla00 0016 09

Gla00 0016 09
Illustration showing an intravenous infusion setup with an IV bag connected via tubing to a needle inserted into a person's arm. The IV bag is elevated on a stand, and the setup depicts the route of administration for an intravenous injection.*
FDA Label Image

Gla00 0016 10

Gla00 0016 10
The packaging label for GLASSIA 1 g/50 mL injection solution, a plasma derivative containing alpha-1 proteinase inhibitor human, manufactured by Takeda Pharmaceuticals America, Inc. The sterile intravenous solution comes in a 50 mL vial and includes one single-use filter needle. The label includes storage instructions, product contents, and manufacturer details, as well as barcodes and trademark information.*
FDA Label Image

Gla00 0016 11

Gla00 0016 11
Label for GLASSIA 1 g/50 mL injection solution, an alpha-1 proteinase inhibitor human intravenous dose form. The label states it is preservative and stabilizer free, sterile, pyrogen free, single-use vial, stored at 2°C to 8°C. Manufactured by Takeda Pharmaceuticals U.S.A., Inc. The label includes the NDC 0944-2884-02, barcode, and usage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.